| SAGE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SAGE Shares Outstanding History and SAGE YTD Return |
| SAGE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-3.69% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SAGE Stock Price Chart |
| About Sage Therapeutics Inc |
| Sage Therapeutics, Inc. is a biopharmaceutical company. Co. has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Co. is targeting diseases and disorders of the brain across its clinical development and earlier stage pipeline. Its product ZURZUVAE is for the treatment of postpartum depression (PPD) in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABA receptors, targeting both synaptic and extra synaptic GABA receptors. Its product ZULRESSO (brexanolone) CIV injection is for the treatment of PPD in individuals 15 years old and older. We show 41 historical shares outstanding datapoints in our SAGE shares outstanding history coverage, used to compute SAGE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SAGE market cap history over the course of time is important for investors interested in comparing SAGE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SAGE versus a peer is one thing; comparing SAGE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SAGE can fluctuate over the course of history. With this page we aim to empower investors researching SAGE by allowing them to research the SAGE market cap history. |
| SAGE Current Stock Quote |
 Free SAGE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SAGE Share Performance |
| Market Cap Peers |
| Sage Therapeutics (SAGE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SANA Market Cap History |
